Serogroup C Neisseria meningitidis disease epidemiology, seroprevalence, vaccine effectiveness and waning immunity, England, 1998/99 to 2015/16

BACKGROUND: In 1999, the United Kingdom (UK) was the first country to introduce meningococcal group C (MenC) conjugate vaccination. This vaccination programme has evolved with further understanding, new vaccines and changing disease epidemiology. AIM: To characterise MenC disease and population prot...

Descripción completa

Detalles Bibliográficos
Autores principales: Findlow, Helen, Campbell, Helen, Lucidarme, Jay, Andrews, Nick, Linley, Ezra, Ladhani, Shamez, Borrow, Ray
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325668/
https://www.ncbi.nlm.nih.gov/pubmed/30621818
http://dx.doi.org/10.2807/1560-7917.ES.2019.24.1.1700818

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325668/
https://www.ncbi.nlm.nih.gov/pubmed/30621818
http://dx.doi.org/10.2807/1560-7917.ES.2019.24.1.1700818

Ejemplares similares